These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

936 related items for PubMed ID: 24211615

  • 1. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K, Jono H, Kugimiya-Taguchi T, Nagao S, Su Y, Yamasaki K, Mizuguchi M, Maruyama T, Ando Y, Otagiri M.
    Life Sci; 2013 Dec 18; 93(25-26):1017-22. PubMed ID: 24211615
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antibody therapy for familial amyloidotic polyneuropathy.
    Su Y, Jono H, Torikai M, Hosoi A, Soejima K, Guo J, Tasaki M, Misumi Y, Ueda M, Shinriki S, Shono M, Obayashi K, Nakashima T, Sugawara K, Ando Y.
    Amyloid; 2012 Jun 18; 19 Suppl 1():45-6. PubMed ID: 22506915
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.
    Wei L, Kawano H, Fu X, Cui D, Ito S, Yamamura K, Ishihara T, Tokuda T, Higuchi K, Maeda S.
    Amyloid; 2004 Jun 18; 11(2):113-20. PubMed ID: 15478467
    [Abstract] [Full Text] [Related]

  • 7. Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine.
    Obayashi K, Tasaki M, Jono H, Ueda M, Shinriki S, Misumi Y, Yamashita T, Oshima T, Nakamura T, Ikemizu S, Anan I, Suhr O, Ando Y.
    Clin Chim Acta; 2013 Apr 18; 419():127-31. PubMed ID: 23462670
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF, Magalhães R, Freitas J, Taipa R, Pires MM, Osório H, Dias D, Pessegueiro H, Correia M, Coelho T.
    J Neurol Neurosurg Psychiatry; 2015 Feb 18; 86(2):159-67. PubMed ID: 25091367
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy.
    Ueda M, Misumi Y, Mizuguchi M, Nakamura M, Yamashita T, Sekijima Y, Ota K, Shinriki S, Jono H, Ikeda S, Suhr OB, Ando Y.
    Clin Chem; 2009 Jun 18; 55(6):1223-7. PubMed ID: 19372189
    [Abstract] [Full Text] [Related]

  • 15. Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy.
    Magalhães J, Saraiva MJ.
    J Neuropathol Exp Neurol; 2011 Dec 18; 70(12):1097-106. PubMed ID: 22082661
    [Abstract] [Full Text] [Related]

  • 16. A rapid and sensitive prenatal diagnosis of familial amyloidotic polyneuropathy ATTR Val30Met by mass spectrometry.
    Yamashita T, Ando Y, Ueda M, Okamoto S, Misumi Y, Nakamura M, Takashi O, Uchino M.
    Prenat Diagn; 2009 Oct 18; 29(10):930-3. PubMed ID: 19609897
    [Abstract] [Full Text] [Related]

  • 17. A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation.
    Jesus CS, Almeida ZL, Vaz DC, Faria TQ, Brito RM.
    Int J Mol Sci; 2016 Aug 31; 17(9):. PubMed ID: 27589730
    [Abstract] [Full Text] [Related]

  • 18. Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis.
    Ueda M, Ando Y, Haraoka K, Katsuragi S, Terasaki Y, Sugimoto M, Sun X, Uchino M.
    Amyloid; 2006 Mar 31; 13(1):24-30. PubMed ID: 16690497
    [Abstract] [Full Text] [Related]

  • 19. Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.
    Tasaki M, Ueda M, Obayashi K, Koike H, Kitagawa K, Ogi Y, Jono H, Su Y, Suenaga G, Oshima T, Misumi Y, Yoshida M, Yamashita T, Sobue G, Ando Y.
    Int J Cardiol; 2013 Dec 05; 170(1):69-74. PubMed ID: 24182678
    [Abstract] [Full Text] [Related]

  • 20. Evidence of the presence of amyloid substance in the blood of familial amyloidotic polyneuropathy patients with ATTR Val30Met mutation.
    Liu J, Lan J, Zhao P, Zheng F, Song J, Zhang P, Sun X.
    Int J Clin Exp Pathol; 2014 Dec 05; 7(11):7795-800. PubMed ID: 25550818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.